BRIEF-Health Canada Issues Resverlogix Authorization To Begin Immediate Clinical Studies Of Apabetalone For Covid-19
- ByReuters-
April 12 (Reuters) - Resverlogix Corp RVX.TO :* HEALTH CANADA ISSUES RESVERLOGIX AUTHORIZATION TO BEGIN IMMEDIATE CLINICAL STUDIES OF APABETALONE FOR COVID-19* RESVERLOGIX CORP -...